Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $414.22 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $75.33 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $63.20 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $61.51 | 3 | $0 (2024) |
| Abbott Laboratories | $40.88 | 2 | $0 (2022) |
| PFIZER INC. | $32.80 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $26.92 | 2 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.18 | 1 | $0 (2022) |
| EKOS Corporation | $20.92 | 1 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $19.59 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.45 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.88 | 1 | Novartis Pharmaceuticals Corporation ($23.88) |
| 2023 | $51.24 | 3 | AstraZeneca Pharmaceuticals LP ($32.79) |
| 2022 | $131.54 | 7 | Abbott Laboratories ($40.88) |
| 2021 | $12.81 | 1 | Janssen Pharmaceuticals, Inc ($12.81) |
| 2020 | $37.63 | 2 | Novartis Pharmaceuticals Corporation ($37.63) |
| 2019 | $55.02 | 3 | E.R. Squibb & Sons, L.L.C. ($22.79) |
| 2018 | $58.95 | 3 | E.R. Squibb & Sons, L.L.C. ($24.07) |
| 2017 | $43.15 | 3 | PFIZER INC. ($14.57) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: DIABETES | ||||||
| 01/31/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardio-renal | ||||||
| 12/13/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Gastroenterology | ||||||
| 11/30/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes Care | ||||||
| 11/22/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes Care | ||||||
| 09/16/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/01/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/24/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Cardiovascular | ||||||
| 10/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/29/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2019 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2019 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/13/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.79 | General |
| Category: Cardiovascular | ||||||
| 06/20/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.07 | General |
| Category: Cardiovascular | ||||||
| 05/24/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2018 | EKOS Corporation | EKOSONIC (Device) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: PERIPHERAL VASCULAR | ||||||
| 12/08/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/25/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2017 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug), DIFICID | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 171 | 181 | $89,268 | $21,665 |
| 2022 | 4 | 95 | 114 | $21,980 | $11,340 |
| 2021 | 5 | 153 | 173 | $55,822 | $19,309 |
| 2020 | 7 | 358 | 488 | $116,296 | $46,245 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 96 | 101 | $59,161 | $14,287 | 24.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 38 | 39 | $16,610 | $4,194 | 25.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 17 | 17 | $7,511 | $1,615 | 21.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 24 | $5,987 | $1,569 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 42 | $7,980 | $4,155 | 52.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $6,090 | $2,746 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $3,200 | $2,234 | 69.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 35 | $4,710 | $2,205 | 46.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 46 | 47 | $21,157 | $7,590 | 35.9% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 28 | 29 | $11,595 | $4,380 | 37.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 33 | 40 | $9,803 | $3,356 | 34.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 39 | $7,991 | $2,362 | 29.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 18 | 18 | $5,277 | $1,622 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 83 | 142 | $32,518 | $12,606 | 38.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 61 | 63 | $27,342 | $11,403 | 41.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 89 | 154 | $24,332 | $9,443 | 38.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 72 | 75 | $17,700 | $6,763 | 38.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 17 | 17 | $6,766 | $2,839 | 42.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 13 | 13 | $3,822 | $1,667 | 43.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 23 | 24 | $3,816 | $1,524 | 39.9% |
About Dr. Flora Parvin, MD
Dr. Flora Parvin, MD is a Internal Medicine healthcare provider based in Newtown, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1649420621.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Flora Parvin, MD has received a total of $414.22 in payments from pharmaceutical and medical device companies, with $23.88 received in 2024. These payments were reported across 23 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($414.22).
As a Medicare-enrolled provider, Parvin has provided services to 777 Medicare beneficiaries, totaling 956 services with total Medicare billing of $98,559. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Newtown, CT
- Active Since 09/25/2008
- Last Updated 11/16/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649420621
Products in Payments
- ELIQUIS (Drug) $81.43
- ENTRESTO (Drug) $61.51
- FARXIGA (Drug) $48.73
- XARELTO (Drug) $26.92
- BRILINTA (Drug) $26.60
- XIFAXAN (Drug) $22.18
- EKOSONIC (Device) $20.92
- FREESTYLE LIBRE (Device) $20.44
- FREESTYLE LIBRE 2 (Device) $20.44
- LifeVest (Device) $19.59
- JARDIANCE (Drug) $18.45
- Kerendia (Drug) $17.97
- CHANTIX (Drug) $14.57
- NOXAFIL (Drug) $14.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newtown
Jennifer Holloway, M.d, M.D
Internal Medicine — Payments: $23,629
Peter Licht, M.d, M.D
Internal Medicine — Payments: $16,931
Anil Patel, M.d, M.D
Internal Medicine — Payments: $12,019
Jeffrey Friedman, Md, MD
Internal Medicine — Payments: $4,912
Giacomo Mangiaracina, Md, MD
Internal Medicine — Payments: $3,284
Dr. Waseem Butt, Md, MD
Internal Medicine — Payments: $726.09